CANB.V - CanadaBis Capital Inc.
| Previous Close | 0.3000 |
| Open | 0.3300 |
| Bid | 0.3100 x N/A |
| Ask | 0.3350 x N/A |
| Day's Range | 0.3300 - 0.3400 |
| 52 Week Range | 0.2500 - 0.6800 |
| Volume | 3,310 |
| Avg. Volume | 9,406 |
| Market Cap | 37.911M |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0460 |
| Earnings Date | Aug 26, 2019 - Aug 30, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CNW GroupCanadaBis Capital Acquires Goldstream Cannabis Inc.
CALGARY, Aug. 13, 2019 /CNW/ - CanadaBis Capital Inc. ("CanadaBis" or "the Company") is pleased to announce it has entered into an agreement to acquire 95% of the outstanding shares of Goldstream Cannabis Inc. ("Goldstream") located in British Columbia. Goldstream holds the right to use 13 acres of land, through an existing lease agreement, with the potential to access up to an additional 300 acres and is zoned for the outdoor cultivation of cannabis. Malahat First Nations currently holds a 5% interest in Goldstream and has indicated their intention to maintain this interest after the transaction.
CNW GroupCanadaBis Capital Achieves Positive Results of Second Test Lot and Appoints Market Maker
CALGARY, Aug. 8, 2019 /CNW/ - CanadaBis Capital Inc. ("CanadaBis" or "the Company"), and its wholly owned subsidiary, 1998643 AB Ltd. ("Stigma Grow"), a licensed cannabis producer under the Cannabis Act, is pleased to announce that it has successfully passed microbial testing of its second crop required by Health Canada under the CTLS system. CanadaBis will now apply to amend its existing Health Canada sales license to include dried flower and oils and, once approved, will be in a position to begin supplying Alberta with their unique, high-quality craft cannabis products. Travis McIntyre, President and Founder of CanadaBis stated, "With the approval of the successful submission of material for analytical testing, we will soon be in a position to expand our product offerings from fresh flower to dried flower and oils.
- Simply Wall St.
Is CanadaBis Capital (CVE:CANB) Weighed On By Its Debt Load?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
CNW GroupCanadaBis Capital Acquires High-quality Cannabis Extraction Company "Full Spectrum Labs"
CALGARY, July 24, 2019 /CNW/ - CanadaBis Capital Inc. ("CanadaBis" or "the Company") has acquired Full Spectrum Labs Ltd., a private corporation which holds intellectual property (IP) and the physical equipment for an extraction methodology to preserve all of the phytocannabinoids and terpenes from cannabis by utilizing an extreme low-temperature process to create the Company's future concentrates. This method will allow the Company to produce a unique variety of finished goods such as tinctures, vapes and oils. With this acquisition, CanadaBis will also be in position to start accepting third-party material from other cannabis licensed producers for toll processing to increase its current cash flows and provide the market with alternative concentrates or oils.
CNW GroupCanadaBis Capital Appoints Donald (Don) Cowie to Their Board
CALGARY, July 22, 2019 /CNW/ - CanadaBis Capital Inc. ("CanadaBis" or "the Company") is pleased to announce that Donald Cowie has joined their Board of Directors. From 1992 to 2002, Mr. Cowie was the head of corporate and investment banking for the Bank of America. Prior to 2002, he served in officer and director roles for several junior oil and gas companies and financial companies with a focus on the oil and gas sector.
- ACCESSWIRE
CanadaBis Capital Corporate Update
CALGARY, AB / ACCESSWIRE / July 15, 2019 / CanadaBis Capital Inc. (“CanadaBis” or “the Company”), a licensed cannabis producer under the Cannabis Act, is pleased to announce that it has completed its second cannabis harvest and has submitted dried samples for analytical testing. Upon completion of analytical testing, CanadaBis will amend its existing Health Canada sales license to include dried flower and oils. Travis McIntyre, President and Founder of CanadaBis stated, "With the completion of the submission of material for analytical testing, we will soon be in a position to expand our product offerings from fresh flower to dried flower and oils.
- ACCESSWIRE
CanadaBis Capital Acquires Retail Location
CALGARY, AB / ACCESSWIRE / July 2, 2019 / CanadaBis Capital Inc. ("CanadaBis" or "the Company") has entered into an agreement to acquire all the outstanding shares of 2103157 Alberta Ltd. operating as Indicative Collection (the "Acquiree"), which holds a cannabis retail store development license in Red Deer, Alberta. Located in the heart of Gasoline Alley, this storefront will face one of Alberta's busiest avenues and provide easy access to travelers passing through the Red Deer hub. Regulatory approvals, including municipal, as well as Alberta Gaming, Liquor & Cannabis ("AGLC") have been obtained and the store is in the final stages of opening.
- ACCESSWIRE
CanadaBis Capital Launches Partnership in Education with Olds College
CALGARY, AB / ACCESSWIRE / May 27, 2019 / CanadaBis Capital Inc. ("CanadaBis" or "The Company") through its wholly owned subsidiary Stigma Grow ("Stigma") is proud to launch a new partnership in education with Olds College. Stigma will participate in the "Cannabis Production Program" offered through Olds College by allowing students "hands on" training and experience opportunities in a cannabis work environment. After students complete their four online courses, they will complete their field study at Stigma's newly licensed facility in Red Deer County, which will prepare the individuals for future employment in the Cannabis Industry.
- ACCESSWIRE
CanadaBis Capital Harvests First Crop.
CALGARY, AB / ACCESSWIRE / May 13, 2019 / CanadaBis Capital Inc. ("CanadaBis" or the "Company") is proud to announce that its solely owned subsidiary Stigma Grow ("Stigma") has completed harvest number one under the Health Canada Cultivation License. Stigma's first crop produced an ultra-premium, quality crop with great terpene profiles. Stigma is midway through cultivation of the second crop using another of its proven genetics and anticipates harvest to be completed by early July, 2019.
